Raub Brock Capital Management LP Has Upped By $467,432 Its Scripps Networks Interactive (SNI) Holding; Last Week BioMarin Pharmaceutical Inc. (BMRN) Analysts

October 11, 2017 - By Adrian Erickson

Among 26 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 18 have Buy rating, 0 Sell and 8 Hold. Therefore 69% are positive. BioMarin Pharmaceutical had 66 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Buy” rating by Goldman Sachs on Wednesday, November 18. The firm earned “Buy” rating on Thursday, July 6 by BMO Capital Markets. Piper Jaffray downgraded the stock to “Neutral” rating in Monday, November 7 report. Piper Jaffray maintained BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) rating on Friday, August 5. Piper Jaffray has “Overweight” rating and $120 target. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, August 5. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Outperform” rating given on Monday, January 23 by Credit Suisse. The company was maintained on Tuesday, July 18 by Leerink Swann. Jefferies maintained it with “Buy” rating and $116.0 target in Monday, September 25 report. The company was initiated on Tuesday, February 7 by Morgan Stanley. As per Thursday, December 8, the company rating was initiated by Gabelli. See BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) latest ratings:

06/10/2017 Broker: Goldman Sachs Rating: Buy New Target: $124.0
06/10/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $115 New Target: $117 Maintain
03/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $115.0 Maintain
25/09/2017 Broker: Jefferies Rating: Buy New Target: $116.0 Maintain
13/09/2017 Broker: BMO Capital Markets Rating: Buy New Target: $117.0 Maintain
15/09/2017 Broker: RBC Capital Markets Rating: Sector Perform New Target: $93 Initiates Coverage On
14/09/2017 Broker: PiperJaffray Old Rating: Neutral New Rating: Overweight Reinitiate
30/08/2017 Broker: Citigroup Rating: Buy New Target: $98.0 Initiate
24/08/2017 Broker: Jefferies Rating: Buy New Target: $116.0 Maintain
17/08/2017 Broker: Evercore Rating: Outperform Initiates Coverage On

Raub Brock Capital Management Lp increased Scripps Networks Interactive (SNI) stake by 3.62% reported in 2017Q2 SEC filing. Raub Brock Capital Management Lp acquired 6,874 shares as Scripps Networks Interactive (SNI)’s stock declined 10.51%. The Raub Brock Capital Management Lp holds 196,852 shares with $13.45 million value, up from 189,978 last quarter. Scripps Networks Interactive now has $11.00 billion valuation. The stock decreased 0.83% or $0.71 during the last trading session, reaching $84.75. About 971,623 shares traded or 7.30% up from the average. Scripps Networks Interactive, Inc. (NYSE:SNI) has risen 9.83% since October 11, 2016 and is uptrending. It has underperformed by 6.87% the S&P500.

BioMarin Pharmaceutical Inc. is a biotechnology company. The company has market cap of $16.64 billion. The Firm develops and commercializes pharmaceuticals for various diseases and medical conditions. It currently has negative earnings. As of December 31, 2016, the Company’s therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates.

The stock increased 0.64% or $0.6 during the last trading session, reaching $94.93. About 1.38M shares traded or 2.99% up from the average. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since October 11, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.06, from 1.2 in 2017Q1. It increased, as 23 investors sold BioMarin Pharmaceutical Inc. shares while 124 reduced holdings. 51 funds opened positions while 134 raised stakes. 168.09 million shares or 1.78% more from 165.15 million shares in 2017Q1 were reported. Royal National Bank & Trust Of Canada reported 42,166 shares or 0% of all its holdings. Moreover, Geneva Advsr Ltd Liability Corporation has 0.03% invested in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Bluecrest Cap Management Limited accumulated 8,550 shares. 16,160 are held by Rafferty Asset Management Ltd Company. Secor Cap Advisors Lp accumulated 0.22% or 26,404 shares. Howe Rusling has invested 0% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Cubist Systematic Strategies Limited has invested 0.04% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). 1.71M were reported by Franklin. Td Asset Mgmt Inc, Ontario – Canada-based fund reported 63,159 shares. Fort Washington Inv Advsrs Oh invested 0.01% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). State Common Retirement Fund reported 478,790 shares. Rhenman & Prns Asset Mngmt reported 189,300 shares. Clough Cap L P reported 0.32% stake. Highland L P has invested 0.01% of its portfolio in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Symphony Asset Mngmt Ltd Limited Liability Company holds 0.07% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) or 6,465 shares.

Since April 28, 2017, it had 0 insider buys, and 14 selling transactions for $7.91 million activity. BIENAIME JEAN JACQUES had sold 10,000 shares worth $960,850 on Friday, April 28. Another trade for 4,486 shares valued at $444,114 was made by Ajer Jeffrey Robert on Friday, May 5. On Friday, June 16 the insider FUCHS HENRY J sold $1.35 million. Davis George Eric sold $862,230 worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Monday, June 5. On Friday, April 28 the insider Mueller Brian sold $687,334. $337,500 worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was sold by LAWLIS V BRYAN on Friday, June 16.

Among 19 analysts covering Scripps Networks (NYSE:SNI), 4 have Buy rating, 2 Sell and 13 Hold. Therefore 21% are positive. Scripps Networks had 47 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Wednesday, August 10. Wells Fargo initiated the shares of SNI in report on Thursday, July 20 with “Hold” rating. The rating was upgraded by Stifel Nicolaus to “Buy” on Wednesday, July 20. The stock of Scripps Networks Interactive, Inc. (NASDAQ:SNI) earned “Hold” rating by Cowen & Co on Friday, July 7. On Monday, October 5 the stock rating was downgraded by Goldman Sachs to “Sell”. Evercore downgraded the stock to “Hold” rating in Thursday, August 11 report. The stock of Scripps Networks Interactive, Inc. (NASDAQ:SNI) has “Sector Perform” rating given on Tuesday, October 20 by RBC Capital Markets. As per Thursday, August 17, the company rating was maintained by RBC Capital Markets. The stock has “Hold” rating by Cowen & Co on Wednesday, September 6. The firm has “Neutral” rating by Citigroup given on Friday, August 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Adrian Erickson




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: